Currently Viewing:
ACO & Emerging Healthcare Delivery Coalition®
Dr Justin Bachmann Discusses Cardiac Rehabilitation in Patients
February 08, 2018
Dr Justin Bachmann on How Cardiology Is Handling Transition to Value-Based Care
January 22, 2018
Dr Justin Bachmann Discusses Consequences of Value-Based Care Being Done Incorrectly
January 06, 2018
Dr Shantanu Agrawal: How Quality Measures Help to Address Health Inequities
December 31, 2017
Dr Shantanu Agrawal on the Challenge of Adjusting Measures for Social Risk Factors
December 14, 2017
Dr Mark Friedberg Discusses His Findings on Workplace Conditions in FQHCs
December 05, 2017
Barbara Balik: Why Clinician Burnout Needs to Be Addressed
November 29, 2017
Clay Alspach Explains How Changes in the FDA Will Affect Biosimilars
November 27, 2017
Dr Frank James: Working to Increase Access to Medication-Assisted Treatment
November 26, 2017
Barbara Balik Explains the Biggest Stressors That Cause Clinician Burnout
November 19, 2017
Dr Justin Bachmann: Challenges of Implementing Behavioral Interventions in Cardiac Care
November 18, 2017
Currently Reading
Dr Frank James Discusses Responses to the Opioid Epidemic
November 11, 2017
Dr Frank James on Improving Treatment for Addiction
November 01, 2017
The Challenge of Adjusting Health Measures for Social Risk Factors
October 30, 2017
Navigating the Politics of the Healthcare Landscape
October 30, 2017
Making the Case for Integrated Care and Physician Engagement With Addiction Patients
October 30, 2017
Dr Shantanu Agrawal: Incorporating Social Risk Factors Into Performance Measures
October 28, 2017
5 Important Healthcare Issues Discussed at the ACO Coalition Meeting
October 28, 2017

Dr Frank James Discusses Responses to the Opioid Epidemic

How the president classifies the opioid epidemic matter doesn't matter as much as attention to it and dedication to responding it, said Frank James, MD, JD, of American Society of Addiction Medicine.


How the president classifies the opioid epidemic matter doesn't matter as much as attention to it and dedication to responding it, said Frank James, MD, JD, of American Society of Addiction Medicine.

Transcript (slightly modified)

The president has declined to declare the opioid epidemic in the country a national emergency, instead calling it a public health emergency. What is the difference in response efforts to the epidemic?

I think that it doesn’t really matter what we call it because calling it something isn’t going to solve the problem. It’s really a matter of now we know it’s a problem, people are dying of it every day, and that we have to address it. So, it’s more important what we do about it, how we approach treatments, how we measure outcomes, how we ensure that people are getting the right care at the right time—regardless of what we want to call it.

How is the way the healthcare industry is responding to the opioid epidemic changing as the situation continues to grow?

The industry’s realizing that addiction medicine is a specialty and that opiate addiction is a chronic disease. We can’t treat that as we treated other addictions—it’s a disease in of itself.

So, recognizing that first, now the industry can then look at what’s the research, what’s the data, what are the outcomes we want to achieve in treating opiate addiction. Then we look at the research to see what is the evidence based treatment that we need to bring to our members, to our patients, and to the industry to make sure that people are getting the right treatment, at the right time, and at the right place; that’s evidence based, that’s based on data and research.

 
Copyright AJMC 2006-2018 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
x
Welcome the the new and improved AJMC.com, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up
×

Sign In

Not a member? Sign up now!